Synthesis and biological evaluation of novel N6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5′-uronamides as A3 adenosine receptor agonists

Journal of Medicinal Chemistry

Volumn 47, Issue 22, 2004, Pages 5535-5540

  Baraldi, Pier Giovanni ^a   Fruttarolo, Francesca ^a   Tabrizi, Mojgan Aghazadeh ^a   Romagnoli, Romeo ^a   Preti, Delia ^a   Bovero, Andrea ^a   Pineda De Las Infantas, Maria Josè ^b   Moorman, Allan ^c   Varani, Katia ^a   Borea, Pier Andrea ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF GRANADA   (Spain)

^c King Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 5' CARBOXAMIDE DERIVATIVE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ADENOSINE; AMIDES; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; HUMANS; LIGANDS; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; URONIC ACIDS;

EID: 6044239448     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0408161     Document Type: Article

References (22)

1. Fredholm, B. B.; Arslan, G.; Halldner, L.; Kull, B.; Schulte, G.; Wasserman, W. Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 364-374.
2. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7432-7436.
3. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 1994, 263, 59-67.
4. 3 adenosine receptors. Mol. Pharmacol. 2000, 57, 968-975.
5. 3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 1995, 115, 945-952.
6. 3 adenosine receptor antagonists. J. Med. Chem. 1997, 40, 2596-2608.
7. Jacobson, K. A.; van Rhee, A. M. Development of selective purinoreceptor agonists and antagonists. In Purinergic Approaches Experimental Therapy; Jacobson, K. A., Jarvis, M. F., Eds; Wiley-Liss Publisher: New York, 1997; pp 101-128.
8. 3 adenosine receptors. Mol. Pharmacol. 2001, 57, 968-975.
9. 3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol. Pharmacol. 2002, 61, 415-424.
10. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
11. 3-selective adenosine agonists. J. Med. Chem. 1994, 37, 636-646.
12. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978, 982.
13. 3 adenosine receptors. J. Med. Chem. 1994, 37, 3373-3382.
14. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
15. 3 Adenosine Receptors. J. Med. Chem. 1996, 39, 802-806.
16. 3 adenosine receptor agonists. J. Med. Chem. 1998, 41, 3174-3185.
17. Kurita, K.; Iwakura, Y. Trichloromethyl-Chloroformate as a phosgene equivalent: 3-isocyanatopropanoylchloride. Organic Synthesis; Wiley and Sons: New York, 1988; Collect. Vol. VI, pp 715-718.
18. Klotz, K. N.; Hessling, J.; Hegler, J.; Owman, C.; Kull, B.; Fredholm, B. B.; Lohse, M J. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 1998, 357, 1-9.
19. 1 adenosine receptors. J. Biol. Chem. 1985, 260, 14659-14664.
20. Bradford, M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem. 1976, 72, 248-254.
21. 50) of an enzymatic reaction. Biochem. Pharmacol. 1983, 22, 3099-3108.
22. Munson, P. J.; Rodbard, D. Ligand: a versatile computerized approach for the characterization of ligand binding system. Anal. Biochem. 1980, 107, 220-239.